BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 3517784)

  • 21. Fungal infections inducing HLA-DR but not HLA-DQ transplantation antigens on keratinocytes.
    Johansson S; Scheynius A; Faergemann J
    Acta Derm Venereol; 1986; 66(4):277-80. PubMed ID: 2430394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of distinct subpopulations of Langerhans cells by flow cytometry and sorting.
    Vaigot P; Czernielewski J; Prunieras M
    Cytometry; 1985 Sep; 6(5):422-7. PubMed ID: 2931262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunochemical analysis of the Ia polymorphisms among the family of DR7-associated HLA-D specificities.
    Karr RW
    J Immunol; 1986 Feb; 136(3):999-1006. PubMed ID: 3510255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-gamma modulates HLA class II antigen expression on cultured human thymic epithelial cells.
    Berrih S; Arenzana-Seisdedos F; Cohen S; Devos R; Charron D; Virelizier JL
    J Immunol; 1985 Aug; 135(2):1165-71. PubMed ID: 3925000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression of HLA-DR antigen in cutaneous malignant lymphomas and recombinant gamma interferon induces HLA-DR antigen on cultured human keratinocytes].
    Kameyama K; Tone T; Eto H; Takezaki S
    Nihon Hifuka Gakkai Zasshi; 1986 Apr; 96(5):483-91. PubMed ID: 2426482
    [No Abstract]   [Full Text] [Related]  

  • 26. A human-human hybridoma antibody (TrB12) defining subgroups of HLA-DQw1 and -DQw3.
    Kolstad A; Hansen T; Hannestad K
    Hum Immunol; 1987 Nov; 20(3):219-31. PubMed ID: 2830209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: identification of two phenotypically distinct monocyte populations.
    Nuñez G; Giles RC; Ball EJ; Hurley CK; Capra JD; Stastny P
    J Immunol; 1984 Sep; 133(3):1300-6. PubMed ID: 6611370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Keratinocyte and epidermal leukocyte expression of CD36 (OKM5) in benign and malignant skin diseases.
    Lisby S; Ralfkiaer E; Hansen ER; Vejlsgaard GL
    Acta Derm Venereol; 1990; 70(1):18-22. PubMed ID: 1689091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence of HLA-DR antigen biosynthesis by human keratinocytes in disease.
    Volc-Platzer B; Majdic O; Knapp W; Wolff K; Hinterberger W; Lechner K; Stingl G
    J Exp Med; 1984 Jun; 159(6):1784-9. PubMed ID: 6202820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA-DR expression on keratinocytes is a common feature of diseased skin.
    Auböck J; Romani N; Grubauer G; Fritsch P
    Br J Dermatol; 1986 Apr; 114(4):465-72. PubMed ID: 2421756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In situ identification of T lymphocyte subsets and HLA-DR expressing cells in the human skin tuberculin reaction.
    Scheynius A; Klareskog L; Forsum U
    Clin Exp Immunol; 1982 Aug; 49(2):325-30. PubMed ID: 6751638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-2-microglobulin and HLA-DR(Ia)-antigens in normal and pathological skin.
    Tjernlund U
    Acta Derm Venereol Suppl (Stockh); 1981; 94():1-40. PubMed ID: 6169248
    [No Abstract]   [Full Text] [Related]  

  • 33. Generation of rabbit antipeptide antibodies to HLA-class II antigens by the use of synthetic peptides.
    Chersi A; Morganti MC; Chillemi F; Houghten R; Cenciarelli C
    Clin Exp Immunol; 1988 Jul; 73(1):76-81. PubMed ID: 3168331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of HLA-class I and II antigens on basal cell carcinoma].
    Nakamura T; Kageshita T; Hirai S; Kimura T; Yoshii A; Ono T; Arao T
    Nihon Hifuka Gakkai Zasshi; 1990 Dec; 100(14):1431-5. PubMed ID: 2082044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneous populations of class II MHC+ cells in human dermal cell suspensions. Identification of a small subset responsible for potent dermal antigen-presenting cell activity with features analogous to Langerhans cells.
    Meunier L; Gonzalez-Ramos A; Cooper KD
    J Immunol; 1993 Oct; 151(8):4067-80. PubMed ID: 8409386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon.
    Baudeau C; Delarue F; Hé CJ; Nguyen G; Adida C; Peraldi MN; Sraer JD; Rondeau E
    Exp Nephrol; 1994; 2(5):306-12. PubMed ID: 7812737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of major histocompatibility complex class II antigens on human keratinocytes.
    Niedecken H; Lutz G; Bauer R; Kreysel HW
    J Am Acad Dermatol; 1988 Dec; 19(6):1030-7. PubMed ID: 2462575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of CD1a, HLA-DR, and HLA class I expression on viable human Langerhans cells and keratinocytes.
    Meunier L; Vian L; Lagoueyte C; Lavabre-Bertrand T; Duperray C; Meynadier J; Cano JP
    Cytometry; 1996 Dec; 26(4):260-4. PubMed ID: 8979024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new DQw1 associated antigen: HLA-DR'Br'.
    Laundy GJ; Middleton D; Klouda PT
    Tissue Antigens; 1985 Sep; 26(3):210-1. PubMed ID: 3863263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TA10 and 2B3, two new alleles in the HLA-DQ region recognized by monoclonal antibodies.
    Schreuder GM; Maeda H; Koning F; D'Amaro J
    Hum Immunol; 1986 Jun; 16(2):127-36. PubMed ID: 2424871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.